Picture of Luckwel Pharmaceuticals logo

LWEL Luckwel Pharmaceuticals Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
FinancialsHighly SpeculativeMicro Cap

Annual balance sheet for Luckwel Pharmaceuticals, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

2017
March 31st
2018
March 31st
2019
March 31st
2020
March 31st
2021
March 31st
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash
Cash and Short Term Investments0.0290.0180.02600.002
Prepaid Expenses
Total Current Assets0.0470.0180.0270.0170.047
Other Long Term Assets
Total Assets0.0520.0180.0270.0170.047
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities0.3950.1480.8191.350.491
Total Long Term Debt
Total Debt
Total Liabilities0.3950.1480.8191.350.491
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity-0.342-0.129-0.792-1.33-0.444
Total Liabilities & Shareholders' Equity0.0520.0180.0270.0170.047
Total Common Shares Outstanding